| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology Section, Department of Chemical Endocrinology, St Bartholomew’s and the Royal London School of Medicine, and Dentistry, London EC1A 7BE, United Kingdom
To elucidate the mechanism underlying the tissue-specific expression of the ACTH receptor/MC2 receptor (ACTH-R) in the adrenal cortex, we have cloned the mouse ACTH-R promoter. The analysis of the cDNA 5'-end showed an untranslated region of 321 bp, and the ACTH-R gene was demonstrated to be composed of two exons of 113 and 112 bp lying upstream of the single coding exon. S1 nuclease protection assay showed two major transcription start sites separated by 4 bp; 1.8 kb of the 5'-flanking region inserted in a luciferase reporter vector had cell-specific promoter activity because it was functional only in mouse adrenocortical Y1 cells but not in mouse Leydig TM3 cells or fibroblast L cells. There was no dramatic change in the promoter activity in Y1 cells for all the deletions tested up to -113 bp upstream of the transcription start site. In contrast, expression in TM3 cells was switched on from deletion -908 bp, while remaining undetectable in L cells. Site-directed mutagenesis of a steroidogenic factor 1 (SF1)-like site at position -25 bp resulted in a significant reduction in luciferase expression by the promoter in Y1 cells. Gel shift analysis of this site indicated specific binding of a protein in extracts of Y1 and TM3 cells. Moreover, expression of SF1 in L cells induced promoter activity of the construct p(908). In conclusion, cell-specific expression of the mouse ACTH-R appears to be controlled by at least two factors. One of them, most probably SF1, is responsible for steroidogenic cell-specific expression. The other as yet unknown factor binding between position -1236 bp and -908 bp acts as a strong inhibitory factor in nonadrenal steroidogenic cells, resulting in the adrenal-specific expression of ACTH-R.
This article has been cited by other articles:
 |
|
 |
|
  X. Rui, J. Tsao, J. O. Scheys, G. D. Hammer, and B. P. Schimmer Contributions of Specificity Protein-1 and Steroidogenic Factor 1 to Adcy4 Expression in Y1 Mouse Adrenal Cells Endocrinology, July 1, 2008; 149(7): 3668 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Doufexis, H. L. Storr, P. J. King, and A. J. L. Clark Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus FASEB J, December 1, 2007; 21(14): 4095 - 4100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, S. Gondo, T. Okabe, K. Ohe, H. Shirohzu, H. Morinaga, M. Nomura, K. Tani, R. Takayanagi, H. Nawata, et al. Steroidogenic factor 1/adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells J. Mol. Endocrinol., November 1, 2007; 39(5): 343 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Johnston, P. J King, and P. J O'Shaughnessy Effects of ACTH and expression of the melanocortin-2 receptor in the neonatal mouse testis Reproduction, June 1, 2007; 133(6): 1181 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Noon, A. Bakmanidis, A. J L Clark, P. J O'Shaughnessy, and P. J King Identification of a novel melanocortin 2 receptor splice variant in murine adipocytes: implications for post-transcriptional control of expression during adipogenesis J. Mol. Endocrinol., December 1, 2006; 37(3): 415 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Noon, A. J. L. Clark, P. J. O'Shaughnessy, and P. J. King A CCAAT/Enhancer-Binding Protein Site at -87 Is Required for the Activation of a Novel Murine Melanocortin 2-Receptor Promoter at Late Stages during Adipogenesis Endocrinology, December 1, 2006; 147(12): 6019 - 6026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Winnay and G. D. Hammer Adrenocorticotropic Hormone-Mediated Signaling Cascades Coordinate a Cyclic Pattern of Steroidogenic Factor 1-Dependent Transcriptional Activation Mol. Endocrinol., January 1, 2006; 20(1): 147 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Blondet, J Gout, P Durand, M Begeot, and D Naville Expression of the human melanocortin-4 receptor gene is controlled by several members of the Sp transcription factor family J. Mol. Endocrinol., April 1, 2005; 34(2): 317 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gondo, T. Yanase, T. Okabe, T. Tanaka, H. Morinaga, M. Nomura, K. Goto, and H. Nawata SF-1/Ad4BP transforms primary long-term cultured bone marrow cells into ACTH-responsive steroidogenic cells Genes Cells, December 1, 2004; 9(12): 1239 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Noon, A. J. L. Clark, and P. J. King A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lubrano-Berthelier, M. Cavazos, C. Le Stunff, K. Haas, A. Shapiro, S. Zhang, P. Bougneres, and C. Vaisse The Human MC4R Promoter: Characterization and Role in Obesity Diabetes, December 1, 2003; 52(12): 2996 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Beuschlein, C. Mutch, D. L. Bavers, Y. M. Ulrich-Lai, W. C. Engeland, C. Keegan, and G. D. Hammer Steroidogenic Factor-1 Is Essential for Compensatory Adrenal Growth Following Unilateral Adrenalectomy Endocrinology, August 1, 2002; 143(8): 3122 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Tremblay and R. S. Viger GATA Factors Differentially Activate Multiple Gonadal Promoters through Conserved GATA Regulatory Elements Endocrinology, March 1, 2001; 142(3): 977 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Endocr. Rev., February 1, 2001; 22(1): 75 - 110. [Abstract] [Full Text]
|
|
|
|
|
|
C. Aigueperse, P. Val, C. Pacot, C. Darne, E. Lalli, P. Sassone-Corsi, G. Veyssiere, C. Jean, and A. Martinez SF-1 (Steroidogenic Factor-1), C/EBP{beta} (CCAAT/Enhancer Binding Protein), and Ubiquitous Transcription Factors NF1 (Nuclear Factor 1) and Sp1 (Selective Promoter Factor 1) Are Required for Regulation of the Mouse Aldose Reductase-Like Gene (AKR1B7) Expression in Adrenocortical Cells Mol. Endocrinol., January 1, 2001; 15(1): 93 - 111. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. L. Bland, C. A. M. Jamieson, S. F. Akana, S. R. Bornstein, G. Eisenhofer, M. F. Dallman, and H. A. Ingraham Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response PNAS, December 19, 2000; 97(26): 14488 - 14493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Boerboom, N. Pilon, R. Behdjani, D. W. Silversides, and J. Sirois Expression and Regulation of Transcripts Encoding Two Members of the NR5A Nuclear Receptor Subfamily of Orphan Nuclear Receptors, Steroidogenic Factor-1 and NR5A2, in Equine Ovarian Cells during the Ovulatory Process Endocrinology, December 1, 2000; 141(12): 4647 - 4656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sekar, H. A. LaVoie, and J. D. Veldhuis Concerted Regulation of Steroidogenic Acute Regulatory Gene Expression by Luteinizing Hormone and Insulin (or Insulin-Like Growth Factor I) in Primary Cultures of Porcine Granulosa-Luteal Cells Endocrinology, November 1, 2000; 141(11): 3983 - 3992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Frigeri, J. Tsao, W. Czerwinski, and B. P. Schimmer Impaired Steroidogenic Factor 1 (NR5A1) Activity in Mutant Y1 Mouse Adrenocortical Tumor Cells Mol. Endocrinol., April 1, 2000; 14(4): 535 - 544. [Abstract] [Full Text]
|
|
|
|
|
|
V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]
|
|
|
|
|
|
L.-A. Li, E. F-L. Chiang, J.-C. Chen, N.-C. Hsu, Y.-J. Chen, and B.-c. Chung Function of Steroidogenic Factor 1 Domains in Nuclear Localization, Transactivation, and Interaction with Transcription Factor TFIIB and c-Jun Mol. Endocrinol., September 1, 1999; 13(9): 1588 - 1598. [Abstract] [Full Text]
|
|
|
|
|
|
D. Lopez, T. W. Sandhoff, and M. P. McLean Steroidogenic Factor-1 Mediates Cyclic 3',5'-Adenosine Monophosphate Regulation of the High Density Lipoprotein Receptor Endocrinology, July 1, 1999; 140(7): 3034 - 3044. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Reinhart, S. C. Williams, B. J. Clark, and D. M. Stocco SF-1 (Steroidogenic Factor-1) and C/EBP{beta} (CCAAT/Enhancer Binding Protein-{beta}) Cooperate to Regulate the Murine StAR (Steroidogenic Acute Regulatory) Promoter Mol. Endocrinol., May 1, 1999; 13(5): 729 - 741. [Abstract] [Full Text]
|
|
|
|
 |
|
 K.-i. Morohashi, H. Tsuboi-Asai, S. Matsushita, M. Suda, M. Nakashima, H. Sasano, Y. Hataba, C.-L. Li, J. Fukata, J. Irie, et al. Structural and Functional Abnormalities in the Spleen of an mFtz-F1 Gene-Disrupted Mouse Blood, March 1, 1999; 93(5): 1586 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Qiu, C. Frigeri, and B. P. Schimmer A Role for Guanyl Nucleotide-Binding Regulatory Protein {beta}- and {gamma}-Subunits in the Expression of the Adrenocorticotropin Receptor Mol. Endocrinol., December 1, 1998; 12(12): 1879 - 1887. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. A. Crawford, C. Dorn, Y. Sadovsky, and J. Milbrandt Nuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1 Mol. Cell. Biol., May 1, 1998; 18(5): 2949 - 2956. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Sadovsky and P. A. Crawford Developmental and Physiologic Roles of the Nuclear Receptor Steroidogenic Factor-I in the Reproductive System Reproductive Sciences, January 1, 1998; 5(1): 6 - 12. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Jacob, J. Lund, P. Martinez, and L. Hedin Acetylation of Steroidogenic Factor 1 Protein Regulates Its Transcriptional Activity and Recruits the Coactivator GCN5 J. Biol. Chem., September 28, 2001; 276(40): 37659 - 37664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Baig, F. M. Swords, L. A. Noon, P. J. King, L. Hunyady, and A. J. L. Clark Desensitization of the Y1 Cell Adrenocorticotropin Receptor. EVIDENCE FOR A RESTRICTED HETEROLOGOUS MECHANISM IMPLYING A ROLE FOR RECEPTOR-EFFECTOR COMPLEXES J. Biol. Chem., November 21, 2001; 276(48): 44792 - 44797. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
